Long-acting reversible contraception
Long acting reversible contraception: the effective and appropriate use of long-acting reversible contraception
Summary
The NICE clinical guideline on long-acting reversible contraception (LARC) offers the best-practice advice for all women of reproductive age who may wish to regulate their fertility by using LARC methods. It covers specific issues for the use of these methods during the menarche and before the menop ...
June 2006: The recommendation on treating irregular bleeding after insertion of a contraceptive implant has been changed (this is recommendation 1.5.4.2 in the NICE guideline). Although the evidence does show that mifepristone is effective at controlling irregular bleeding associated with implants, it is not licensed for this indication. The revised recommendation reads: 'Irregular bleeding associated with implant use can be treated with mefenamic acid or ethinylestradiol.'
Guidance documents
Implementing this guidance
Other information
Expected review date: October 2010
About this guidance
Clinical guidelines CG30
Issued: October 2005
How this guidance was produced